0.00Open0.00Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover121.22%IV-89.66%PremiumDec 20, 2024Expiry Date18.91Intrinsic Value100Multiplier29DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9663Delta0.0155Gamma1.11Leverage Ratio-0.0070Theta-0.0112Rho-1.07Eff Leverage0.0043Vega
Kiniksa Pharmaceuticals International Stock Discussion
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2 ...
i) Current market- $SPDR S&P 500 ETF (SPY.US)$
ii) Oil price
iii) My trade based on stage analysis
i) To be honest, after the last month CPI showed that the inflation is still not under controlled, the big sell off volume ha...
No comment yet